THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH
Fuente:
Zenodo
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Recurso digital |
| Lingua: | inglese |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901968955375616 |
|---|---|
| author | Dr. Imran Aslam Dr. Muhammad Kalim Raza Dr. Ayesha Ashraf Dr. Vishal Chauhan |
| author_facet | Dr. Imran Aslam Dr. Muhammad Kalim Raza Dr. Ayesha Ashraf Dr. Vishal Chauhan |
| contents | <p><strong><span lang="EN-US">THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH</span></strong></p> <p><strong><span lang="EN-US">Dr. Imran Aslam </span></strong></p> <p><span lang="EN-US">Ph.D.<strong> </strong><span>Research Assistant & Assistant Professor, Department of Pharmacology</span></span></p> <p><span lang="EN-US">Samarkand State Medical University</span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drimran87@gmail.com"><span lang="EN-US">drimran87@gmail.com</span></a></span></span></p> <p><strong><span lang="EN-US">Dr. Muhammad Kalim Raza</span></strong></p> <p><span lang="EN-US">Assistant professor, Samarkand State Medical University, Samarkand, Uzbekistan</span></p> <p><strong><span lang="EN-US">Dr. Ayesha Ashraf</span></strong></p> <p><span lang="EN-US">Assistant Professor, Department Histology/Cytology/Embryology</span></p> <p><span lang="EN-US">Samarkand State Medical University</span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drayesha560@gmail.com"><span lang="EN-US">drayesha560@gmail.com</span></a></span></span></p> <p><strong><span lang="EN-US">Dr. Vishal Chauhan</span></strong></p> <p><span lang="EN-US">Assistant Professor, Department Histology/Cytology/Embryology</span></p> <p><span lang="EN-US">Samarkand State Medical University </span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drimran87@gmail.com"><span lang="EN-US">vishaltinnuchauhan@gmail.com</span></a></span></span><a name="_Toc88742642"></a><strong><span> </span></strong></p> <p><span><strong><span lang="UZ-CYR">https://doi.org/10.5281/zenodo.<span>15161116</span></span></strong></span></p> <p><strong><span lang="EN-US">Abstract: </span></strong><span lang="EN-US">Obesity is a significant global health challenge that increases the chance of developing cardiovascular disorders (CVDs), including heart failure, coronary artery disease, and hypertension. Traditional weight-loss methods often yield limited success, prompting the need for pharmacological interventions. Anti-obesity medications (AOMs) have emerged as effective tools for not only weight reduction but also improving cardiovascular health. This article explores the cardiovascular benefits of AOMs, including their role in lowering blood pressure, improving lipid profiles, reducing inflammation, and enhancing insulin sensitivity. Clinical trials, such as the SELECT and LEADER studies, provide strong evidence that medications like semaglutide, liraglutide, and tirzepatide significantly reduce major cardiovascular events. While AOMs offer promising heart health benefits, they should be integrated into a comprehensive lifestyle approach. This review highlights the transformative impact of anti-obesity medications in reducing cardiovascular risks and improving overall well-being.</span></p> <p><strong><span lang="EN-US">Keywords</span></strong><span lang="EN-US">: Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health.</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_15161116 |
| institution | Zenodo |
| language | eng |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH Dr. Imran Aslam Dr. Muhammad Kalim Raza Dr. Ayesha Ashraf Dr. Vishal Chauhan Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health. <p><strong><span lang="EN-US">THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH</span></strong></p> <p><strong><span lang="EN-US">Dr. Imran Aslam </span></strong></p> <p><span lang="EN-US">Ph.D.<strong> </strong><span>Research Assistant & Assistant Professor, Department of Pharmacology</span></span></p> <p><span lang="EN-US">Samarkand State Medical University</span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drimran87@gmail.com"><span lang="EN-US">drimran87@gmail.com</span></a></span></span></p> <p><strong><span lang="EN-US">Dr. Muhammad Kalim Raza</span></strong></p> <p><span lang="EN-US">Assistant professor, Samarkand State Medical University, Samarkand, Uzbekistan</span></p> <p><strong><span lang="EN-US">Dr. Ayesha Ashraf</span></strong></p> <p><span lang="EN-US">Assistant Professor, Department Histology/Cytology/Embryology</span></p> <p><span lang="EN-US">Samarkand State Medical University</span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drayesha560@gmail.com"><span lang="EN-US">drayesha560@gmail.com</span></a></span></span></p> <p><strong><span lang="EN-US">Dr. Vishal Chauhan</span></strong></p> <p><span lang="EN-US">Assistant Professor, Department Histology/Cytology/Embryology</span></p> <p><span lang="EN-US">Samarkand State Medical University </span></p> <p><span lang="EN-US">E-mail: </span><span><span><a href="mailto:drimran87@gmail.com"><span lang="EN-US">vishaltinnuchauhan@gmail.com</span></a></span></span><a name="_Toc88742642"></a><strong><span> </span></strong></p> <p><span><strong><span lang="UZ-CYR">https://doi.org/10.5281/zenodo.<span>15161116</span></span></strong></span></p> <p><strong><span lang="EN-US">Abstract: </span></strong><span lang="EN-US">Obesity is a significant global health challenge that increases the chance of developing cardiovascular disorders (CVDs), including heart failure, coronary artery disease, and hypertension. Traditional weight-loss methods often yield limited success, prompting the need for pharmacological interventions. Anti-obesity medications (AOMs) have emerged as effective tools for not only weight reduction but also improving cardiovascular health. This article explores the cardiovascular benefits of AOMs, including their role in lowering blood pressure, improving lipid profiles, reducing inflammation, and enhancing insulin sensitivity. Clinical trials, such as the SELECT and LEADER studies, provide strong evidence that medications like semaglutide, liraglutide, and tirzepatide significantly reduce major cardiovascular events. While AOMs offer promising heart health benefits, they should be integrated into a comprehensive lifestyle approach. This review highlights the transformative impact of anti-obesity medications in reducing cardiovascular risks and improving overall well-being.</span></p> <p><strong><span lang="EN-US">Keywords</span></strong><span lang="EN-US">: Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health.</span></p> |
| title | THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH |
| topic | Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health. |
| url | https://doi.org/10.5281/zenodo.15161116 |